Co-delivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for synergistic cancer treatmentJOURNAL OF CONTROLLED RELEASEIF11.52017-08-010PREAI
Lipid-polymer hybrid nanoparticles with aggregation-induced emission (AIE) characteristic for imaging-guided drug deliveryJOURNAL OF CONTROLLED RELEASEIF11.52017-08-010PREAI
Doxorubicin-conjugated magnetic iron oxide nanoparticles for pH-sensitive and magnetic responsive drug deliveryJOURNAL OF CONTROLLED RELEASEIF11.52015-09-0111PREAI
Lipid-polymer hybrid nanoparticles for the delivery of gemcitabineJOURNAL OF CONTROLLED RELEASEIF11.52015-09-014PREAI
Co-delivery of doxorubicin and amphiphilic derivative of Gd-DTPA with lipid-polymer hybrid nanoparticles for simultaneous imaging and targeted therapy of cancerJOURNAL OF CONTROLLED RELEASEIF11.52015-09-012PRE
Anionic long circulating liposomes for hepatic targeted delivery of cisplatinJOURNAL OF CONTROLLED RELEASEIF11.52015-09-015PREAI
Polymer-lipid hybrid nanoparticles with reduction-triggered release for improved antitumor efficiency具有还原触发释放的聚合物-脂质混合纳米颗粒可提高抗肿瘤效率JOURNAL OF CONTROLLED RELEASEIF11.52013-11-013PREAI
Highly efficient loading of amorphous paclitaxel in mesoporous hematite nanorods and their in vitro antitumor activityJOURNAL OF CONTROLLED RELEASEIF11.52013-11-011PRE
Bioreducible cationic micelle/DNA multilayered films for localized gene deliveryJOURNAL OF CONTROLLED RELEASEIF11.52011-11-014PREAI
One-pot preparation of polyethlyenimine/silica hybride nanoparticles as serum-resistant gene delivery vectors: Transfection and intracellular traffickingJOURNAL OF CONTROLLED RELEASEIF11.52011-11-012PREAI
Bioreducible polycationic micelles for in vitro gene deliveryJOURNAL OF CONTROLLED RELEASEIF11.52011-11-012PREAI
Tunable release of biomacromolecules from reductive-responsive multilayered hollow microcapsulesJOURNAL OF CONTROLLED RELEASEIF11.52011-11-012PREAI
Dendrimer modified magnetic iron oxide nanoparticle/dna/pei ternary complexes: A novel strategy for magnetofectionJOURNAL OF CONTROLLED RELEASEIF11.52011-11-0113PREAI